EFFECTS OF INTERLEUKIN-2 ON BONE-RESORPTION AND NATURAL IMMUNITY IN OSTEOPETROTIC (IA) RATS

Citation
Gb. Schneider et M. Relfson, EFFECTS OF INTERLEUKIN-2 ON BONE-RESORPTION AND NATURAL IMMUNITY IN OSTEOPETROTIC (IA) RATS, Lymphokine and cytokine research, 13(6), 1994, pp. 335-341
Citations number
39
Categorie Soggetti
Immunology,Biology
ISSN journal
10565477
Volume
13
Issue
6
Year of publication
1994
Pages
335 - 341
Database
ISI
SICI code
1056-5477(1994)13:6<335:EOIOBA>2.0.ZU;2-K
Abstract
Cells of the immune system and the cytokines they produce have been sh own to function in the regulation of bone turnover. Incisors absent (i a) osteopetrotic rats demonstrate defects in natural immunity and bone resorption, even though they have excess numbers of both natural kill er (NK) cells and osteoclasts. In an attempt to correct these defects, mutant (ia) and normal rats were infused with 3 x 10(4) U recombinant interleukin-2 (rIL-2)/day for 14 days using osmotic minipumps. The ef fects of IL-2 on natural immune function and bone resorption were eval uated after the infusion period. The percentage of NK cells in the spl een after treatment was quantitated by phenotypic analysis using monoc lonal antibodies and flow cytometry. The elevated levels of NK cells n ormally seen in ia mutants were reduced to normal in the IL-2-infused rats. NK cell activity was evaluated by the Cr-51 release assay and fo und to be enhanced to normal killing levels in the IL-2-treated mutant s. The defects in NK function are corrected by IL-2 therapy. Likewise, the bone resorption defect appears to be corrected by the IL-2 infusi ons. The bone marrow cavity size was significantly increased in the IL -2-treated mutants compared with control mutants. Additionally, the pe rcentage of osteoclasts exhibiting normal morphology was significantly increased in the IL-2-treated mutants. The bone density of the caudal vertebrae, evaluated by gray-scale analysis of x-rays, was found to b e reduced in the IL-2-treated mutants. Interleukin-2 corrects both the bone resorption and natural immune defects in the ia mutation.